BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

289 related articles for article (PubMed ID: 20363309)

  • 1. Effect of Chinese prescription Kangen-karyu on lipid metabolism in type 2 diabetic db/db mice.
    Yamabe N; Kim HY; Kang KS; Zhao Q; Matsumoto K; Yokozawa T
    J Ethnopharmacol; 2010 Jun; 129(3):299-305. PubMed ID: 20363309
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Beneficial effects of Chinese prescription Kangen-karyu on diabetes associated with hyperlipidemia, advanced glycation endproducts, and oxidative stress in streptozotocin-induced diabetic rats.
    Kim HY; Okamoto T; Yokozawa T
    J Ethnopharmacol; 2009 Jul; 124(2):263-9. PubMed ID: 19397970
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hepato-/reno-protective activity of Chinese prescription Kangen-karyu through inhibition of AGE formation and fibrosis-related protein expression in type 2 diabetes.
    Okamoto T; Park CH; Noh JS; Toriizuka K; Sei Y; Park JC; Yokozawa T
    J Pharm Pharmacol; 2011 Jul; 63(7):952-9. PubMed ID: 21635261
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Protective effect of Chinese prescription Kangen-karyu and its crude drug Tanjin against age-related lipidosis in rats.
    Cho EJ; Yokozawa T; Okamoto T
    J Pharm Pharmacol; 2007 May; 59(5):687-94. PubMed ID: 17524234
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effectiveness of Chinese prescription Kangen-karyu for dyslipi-demia, using 3T3-L1 adipocytes and type 2 diabetic mice.
    Hum Park C; Young Rhyu D; Sook Noh J; Min Park C; Yokozawa T
    Drug Discov Ther; 2014 Jun; 8(3):121-31. PubMed ID: 25031044
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of proanthocyanidin preparations on hyperlipidemia and other biomarkers in mouse model of type 2 diabetes.
    Lee YA; Cho EJ; Yokozawa T
    J Agric Food Chem; 2008 Sep; 56(17):7781-9. PubMed ID: 18690694
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chinese prescription kangen-karyu ameliorates the development of diabetic hepatic damages via regulating oxidative stress and inflammation in the liver of db/db mice.
    Park CH; Yamabe N; Okamoto T; Toriizuka K; Yokozawa T
    Biol Pharm Bull; 2011; 34(3):383-8. PubMed ID: 21372389
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chinese prescription Kangen-karyu prevents dyslipidaemia and oxidative stress in mouse model of type 2 diabetes.
    Noh JS; Park CH; Kim HY; Zhao Q; Yamabe N; Matsumoto K; Yokozawa T
    J Pharm Pharmacol; 2011 Jan; 63(1):111-9. PubMed ID: 21155823
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of loganin, iridoid glycoside from Corni Fructus, on hepatic and renal glucolipotoxicity and inflammation in type 2 diabetic db/db mice.
    Yamabe N; Noh JS; Park CH; Kang KS; Shibahara N; Tanaka T; Yokozawa T
    Eur J Pharmacol; 2010 Dec; 648(1-3):179-87. PubMed ID: 20826139
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antioxidative effects related to the potential anti-aging properties of the Chinese prescription Kangen-karyu and Carthami Flos in senescence-accelerated mice.
    Satoh A; Yokozawa T; Cho EJ; Okamoto T; Sei Y
    Arch Gerontol Geriatr; 2004; 39(1):69-82. PubMed ID: 15158582
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The protective role of Kangen-karyu against fructose-induced metabolic syndrome in a rat model.
    Yokozawa T; Kim HJ; Yamabe N; Okamoto T; Cho EJ
    J Pharm Pharmacol; 2007 Sep; 59(9):1271-8. PubMed ID: 17883899
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hypoglycemic and hypolipidemic action of Du-zhong (Eucommia ulmoides Oliver) leaves water extract in C57BL/KsJ-db/db mice.
    Park SA; Choi MS; Kim MJ; Jung UJ; Kim HJ; Park KK; Noh HJ; Park HM; Park YB; Lee JS; Lee MK
    J Ethnopharmacol; 2006 Oct; 107(3):412-7. PubMed ID: 16684593
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Beneficial effect of 7-O-galloyl-D-sedoheptulose on oxidative stress and hepatic and renal changes in type 2 diabetic db/db mice.
    Park CH; Noh JS; Yamabe N; Kang KS; Tanaka T; Yokozawa T
    Eur J Pharmacol; 2010 Aug; 640(1-3):233-42. PubMed ID: 20447388
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of Effects of Chinese Prescription Kangen-karyu on Diabetes-Induced Alterations such as Oxidative Stress and Apoptosis in the Liver of Type 2 Diabetic db/db Mice.
    Park CH; Noh JS; Okamoto T; Park JC; Yokozawa T
    Evid Based Complement Alternat Med; 2012; 2012():143489. PubMed ID: 22969821
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Protective effect of the Chinese prescription Kangen-karyu against high glucose-induced oxidative stress in LLC-PK1 cells.
    Yokozawa T; Kim YA; Kim HY; Okamoto T; Sei Y
    J Ethnopharmacol; 2007 Jan; 109(1):113-20. PubMed ID: 16949779
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment with oligonol, a low-molecular polyphenol derived from lychee fruit, attenuates diabetes-induced hepatic damage through regulation of oxidative stress and lipid metabolism.
    Noh JS; Park CH; Yokozawa T
    Br J Nutr; 2011 Oct; 106(7):1013-22. PubMed ID: 21477406
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Scientific evidence for therapeutic effects of Chinese prescription Kangen-karyu from pre-clinical animal experiments.
    Yokozawa T; Park CH; Matsumoto K
    Drug Discov Ther; 2017 Mar; 11(1):6-14. PubMed ID: 28123156
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of 7-O-galloyl-D-sedoheptulose, isolated from Corni Fructus, in the adipose tissue of type 2 diabetic db/db mice.
    Park CH; Tanaka T; Yokozawa T
    Fitoterapia; 2013 Sep; 89():131-42. PubMed ID: 23567861
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Muraglitazar, a novel dual (alpha/gamma) peroxisome proliferator-activated receptor activator, improves diabetes and other metabolic abnormalities and preserves beta-cell function in db/db mice.
    Harrity T; Farrelly D; Tieman A; Chu C; Kunselman L; Gu L; Ponticiello R; Cap M; Qu F; Shao C; Wang W; Zhang H; Fenderson W; Chen S; Devasthale P; Jeon Y; Seethala R; Yang WP; Ren J; Zhou M; Ryono D; Biller S; Mookhtiar KA; Wetterau J; Gregg R; Cheng PT; Hariharan N
    Diabetes; 2006 Jan; 55(1):240-8. PubMed ID: 16380499
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oleanolic acid improves hepatic insulin resistance via antioxidant, hypolipidemic and anti-inflammatory effects.
    Wang X; Liu R; Zhang W; Zhang X; Liao N; Wang Z; Li W; Qin X; Hai C
    Mol Cell Endocrinol; 2013 Aug; 376(1-2):70-80. PubMed ID: 23791844
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.